Lee Hae-Woong, Choo Min-Kyung, Bae Eun-Ah, Kim Dong-Hyun
College of Pharmacy, Kyung Hee University, Seoul, Korea.
Liver Int. 2003 Aug;23(4):221-6. doi: 10.1034/j.1600-0676.2003.00830.x.
BACKGROUND/AIM: To understand the relationship between the fluctuation in serum beta-glucuronidase and hepatotoxicity, an inhibitor of beta-glucuronidase was isolated from the flowers of Pueraria thunbergiana and its hepatoprotective activity was measured.
Tectorigenin was isolated from the flowers of pueria thunbergiana as an inhibitor of beta-glucuronidase, and serum ALT, AST and biological parameters as markers for its hepatoprotective activity were measured on CCl4-induced liver injury in mice. The relationship between serum beta-glucuronidase and hepatoprotective activities in mice was measured.
: When tectorigenin at a dose of 100 mg/kg was intraperitoneally administered on CCl4-induced liver injury in mice, it significantly inhibited the increase of plasma ALT, AST and LDH activities. The inhibitory effect of tectorigenin is much more potent than that of dimethyl diphenyl bicarboxylate (DDB), which has been used as a commercial hepatoprotective agent. When tectoridin transformed to tectorigenin by intestinal bacteria was orally administered to mice, it showed hepatoprotective activity. However, when tectoridin was intraperitoneally administrated to mice, it did not exhibit hepatoprotective activity. Moreover, orally administered tectoridin not only inhibited beta-glucuronidase but also increased GSH content and GST activity on CCl4-induced hepatotoxicity of mice.
We insist that an inhibitor of beta-glucuronidase tectorigenin may be hepatoprotective and tectoridin should be a prodrug transformed to tectorigenin.
背景/目的:为了解血清β-葡萄糖醛酸酶波动与肝毒性之间的关系,从葛根花中分离出一种β-葡萄糖醛酸酶抑制剂,并测定其肝保护活性。
从葛根花中分离出鸢尾黄素作为β-葡萄糖醛酸酶抑制剂,在四氯化碳诱导的小鼠肝损伤模型上,检测血清谷丙转氨酶(ALT)、谷草转氨酶(AST)及相关生物学参数,以评价其肝保护活性。同时测定小鼠血清β-葡萄糖醛酸酶与肝保护活性之间的关系。
当以100mg/kg剂量的鸢尾黄素腹腔注射给四氯化碳诱导肝损伤的小鼠时,可显著抑制血浆ALT、AST和乳酸脱氢酶(LDH)活性的升高。鸢尾黄素的抑制作用比已作为商业肝保护剂使用的联苯双酯更强。当经肠道细菌转化为鸢尾黄素的鸢尾苷口服给予小鼠时,显示出肝保护活性。然而,当鸢尾苷腹腔注射给小鼠时,未表现出肝保护活性。此外,口服鸢尾苷不仅抑制β-葡萄糖醛酸酶,还能增加四氯化碳诱导的小鼠肝毒性模型中谷胱甘肽(GSH)含量和谷胱甘肽S-转移酶(GST)活性。
我们认为β-葡萄糖醛酸酶抑制剂鸢尾黄素可能具有肝保护作用,鸢尾苷应是转化为鸢尾黄素的前体药物。